| Region: | |
| Category: |
(724 reports matching your criteria)
|
Hungary Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... margins and introduced insecurityto an already difficult economic environment, and we continue to expect a contraction in the size of theHungarian pharmaceutical market in 2012 and 2013. Consequently, Hungarian drugmakers will have tobecome even more ...
|
more...
|
$1,175.00
|
|
Serbia Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... consumption is also expected to rise. However, financial inefficiencies within the healthinsurance system mean that the National Health Insurance Institution (RZZO) is unable to always meet itsobligations on time, leaving patients to pay for formerly ...
|
more...
|
$1,175.00
|
|
Romania Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... are a small improvement, though definitely not what producerswould have wanted ideally. With part of the objective of the claw-back tax to improve the timeliness ofpayments for reimbursed medicines, which has been a major difficulty ...
|
more...
|
$1,175.00
|
|
Portugal Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... Portugal has already made considerable savings in the healthcaresectors, with changes such as the introduction of e-prescriptions and prescribing by active ingredients,changes to reference pricing, reductions in pharmacy margins and price cuts just some of ...
|
more...
|
$1,175.00
|
|
Lithuania Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... with the market expected to increase by a local currency margin of 2.5%year-on-year (y-o-y) to reach LTL1.68bn (US$618mn) in 2012 at consumer prices. However, in US dollarterms, the market's value will shrink by 6.3%, indicating ...
|
more...
|
$1,175.00
|
|
Slovakia Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... this is realised. We do not expect either of the two private insurers - Dôvera or DutchownedUnion - will surrender their businesses without a fight, with Union in particular well-placedto oppose the move, potentially invoking ...
|
more...
|
$1,175.00
|
|
Switzerland Pharmaceuticals and Healthcare Report Q1 2013
1/9/2013 | published by: Business Monitor International
... believes the government needs to do more to alter patients' attitudestowards these drugs as this is the main growth deterrent. Headline Expenditure Projections Pharmaceuticals: CHF6.77bn (US$7.63bn) in 2011 to CHF6.58bn (US$7.00bn) in 2012; -2.8% declinein ...
|
more...
|
$1,175.00
|
|
Poland Pharmaceuticals and Healthcare Report Q1 2013
1/2/2013 | published by: Business Monitor International
... has shifted towards the Polishconsumer, as the harsher reimbursement regime has caused private contributions to prescriptionpayments rise. We forecast a return to growth in 2013, driven by private consumption as the Polishgovernment entrenches cuts to ...
|
more...
|
$1,175.00
|
|
Ukraine Pharmaceuticals and Healthcare Report Q1 2013
1/2/2013 | published by: Business Monitor International
... represent a very large business risk for internationaldrugmakers operating in the country. While Ukraine remains one of Central and Eastern Europe (CEE)'smore promising pharmaceutical markets given its favourable demographics and disease profile, itschronic lack of ...
|
more...
|
$1,175.00
|
|
Croatia Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... from the EU. The implementation of a clawbacktax at the start of the year will increase pricing pressures. VAT rises and inflation suggest growth seen in2012 will not be due to increased drug consumption. We ...
|
more...
|
$1,175.00
|
|
Italy Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... theyear. BMI notes that this does not bode well for drugmakers selling their products in Italy as the successof the implemented policies may encourage the enforcement of further cost-containment measures,which, together with the ongoing public ...
|
more...
|
$1,175.00
|
|
Belgium Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... local currency and US dollar terms, largely on account of cost containmentmeasures and patent expirations. Nevertheless, foreign companies are expected to continue using Belgianproduction sites for exports, the country also being a popular re-export source. ...
|
more...
|
$1,175.00
|
|
Bulgaria Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... expected to be used to purchase newequipment, upgrade hospitals and generally improve Bulgarian health services. We have long highlightedthe likelihood of increased public spending ahead of the 2013 parliamentary election, although we do notforesee significant ...
|
more...
|
$1,175.00
|
|
France Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... EUR35.01bn (US$48.66bn) in 2011 to EUR34.17bn (US$43.39bn) in 2012;-2.4% in local currency terms and -10.8% in US dollar terms. Local currency forecast broadlyunchanged from Q312. Healthcare: EUR234.30bn (US$325.68bn) in 2011 to EUR239.29bn (US$303.89bn) in 2012;+2.1% ...
|
more...
|
$1,175.00
|
|
Veterinary Services in France: ISIC 852
12/18/2012 | published by: Euromonitor International
... provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they ...
|
more...
|
$600.00
|
|
Healthcare, Regulatory and Reimbursement Landscape - Denmark
12/12/2012 | published by: GlobalData
... on Denmark`s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights ...
|
more...
|
$1,995.00
|
|
Getting Social With Disease: How Public Health Authorities in Central and Eastern Europe can Improve Outbreak Predictions with Social Media
12/11/2012 | published by: IDC
... whether something "small" like an off-the-shelf analytics application or "large" like a full-scale migration of systems and software to a cloud-based delivery model. Usually this is okay. But in the realm of public health, it ...
|
more...
|
$1,500.00
|
|
Herbal/Traditional Products in Romania
11/22/2012 | published by: Euromonitor International
... by the rural population but also by some urban dwellers with roots in rural regions. Hence, herbal products are intrinsically trusted, and are also not believed to work miraculously. Herbal infusions, for example, are used ...
|
more...
|
$900.00
|
|
Netherlands Renewables Report Q1 2013
11/21/2012 | published by: Business Monitor International
... due to a high level of politicaluncertainty. At this juncture, we believe that a pro-Eurozone coalition will be formed, but are unsure ofthe stance that the government will take on renewables. That said, our long-term ...
|
more...
|
$1,175.00
|
|
Healthcare, Regulatory and Reimbursement Landscape - The Netherlands
11/20/2012 | published by: GlobalData
... and analysis regarding the healthcare, regulatory, and reimbursement landscape in the Netherlands. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure. Most ...
|
more...
|
$1,995.00
|
|
A comprehensive study of the UK Scientific & Laboratory Equipment market in 2010, rating & valuing each of the 650 companies that operate in today's market
11/19/2012 | published by: Plimsoll Publishing Ltd.
... Identify under performing companies for acquisition Seek out successful companies to partner or do business with Understand the key movers and shakers in today’s market Each company receives the following unique features: A 5 year ...
|
more...
|
$350.00
|
|
A comprehensive study of the UK Healthcare Consultants market in 2010, rating & valuing each of the 186 companies that operate in today's market
11/19/2012 | published by: Plimsoll Publishing Ltd.
... Identify under performing companies for acquisition Seek out successful companies to partner or do business with Understand the key movers and shakers in today’s market Each company receives the following unique features: A 5 year ...
|
more...
|
$350.00
|
|
A comprehensive study of the UK Veterinary Surgeons & Practitioners market in 2010, rating & valuing each of the 500 companies that operate in today's market
11/19/2012 | published by: Plimsoll Publishing Ltd.
... Identify under performing companies for acquisition Seek out successful companies to partner or do business with Understand the key movers and shakers in today’s market Each company receives the following unique features: A 5 year ...
|
more...
|
$350.00
|
|
A comprehensive study of the UK Disability Care Services market in 2010, rating & valuing each of the 438 companies that operate in today's market
11/19/2012 | published by: Plimsoll Publishing Ltd.
... Identify under performing companies for acquisition Seek out successful companies to partner or do business with Understand the key movers and shakers in today’s market Each company receives the following unique features: A 5 year ...
|
more...
|
$350.00
|
|
A comprehensive study of the UK Dental Laboratories market in 2010, rating & valuing each of the 422 companies that operate in today's market
11/19/2012 | published by: Plimsoll Publishing Ltd.
... Identify under performing companies for acquisition Seek out successful companies to partner or do business with Understand the key movers and shakers in today’s market Each company receives the following unique features: A 5 year ...
|
more...
|
$350.00
|
